Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's enough to support a dividend set at just $2.66 per share annually and reduce the company's debt load.
Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit moving forward.
Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended the role of PBMs in healthcare.
Troubled drugstore chain CVS Health (CVS) reported Fiscal fourth-quarter results that beat on the top and bottom lines, sending shares sharply
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall Street estimates fourth-quarter adjusted EPS of $0.94 and sales of $97.20 billion,